Patent ID: 11857527
Assignee: SOCIETE DES PRODUITS NESTLE S.A.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 3:
4. A method of treating an individual having a condition or disease that is neurological and/or associated with brain energy deficiency, the method comprising administering a composition comprising medium-chain triglycerides (MCTs) to the individual, wherein the MCTs comprise:
a MCT comprising three fatty acid moieties each with 8 carbon atoms (MCT-C8); and
a MCT comprising three fatty acid moieties each with 10 carbon atoms (MCT-C10);
wherein the ratio of the MCT-C8 to the MCT-C10 is from 50:50 to 67:33 (mol/mol), and
wherein the composition provides increased ketones and/or fatty acids as compared to a composition comprising MCTs comprising three fatty acids moieties each with a mix of C8 and C10 moieties attached and having the same C8/C10 ratio and molar amounts.